Clinical Roundup Wilmot Cancer Institute researchers discover how to steer army of immune cells toward cancer April 21, 2023Vol.49 No.16
Clinical Roundup Keytruda + Cabometyx shows clinical benefit for head and neck squamous cell carcinoma in phase II trial April 14, 2023Vol.49 No.15
Clinical Roundup Medicaid “cliff” adds to racial and ethnic disparities in care for near-poor seniors April 14, 2023Vol.49 No.15
Clinical Roundup UCLA-led research shows that prior treatments influence immunotherapy response in advanced melanoma April 14, 2023Vol.49 No.15
Clinical Roundup New Century Health and Neighborhood Health Plan of Rhode Island study finds increased hypofractionation uptake April 14, 2023Vol.49 No.15
Clinical Roundup ASCO publishes updated guidelines for initial management of noncastrate advanced, recurrent, or metastatic prostate cancer April 07, 2023Vol.49 No.14
Clinical Roundup Study finds more U.S. prostate cancer patients choosing active surveillance April 07, 2023Vol.49 No.14
Clinical Roundup Phase II study shows novel immunotherapy is safe in prostate cancer April 07, 2023Vol.49 No.14
Clinical Roundup Researchers show Lorbrena is safe and effective for patients with ALK-driven R/R high-risk neuroblastoma April 07, 2023Vol.49 No.14
Clinical Roundup NIH study finds that immunotherapy substantially increases survival of people with lymphomatoid granulomatosis April 07, 2023Vol.49 No.14
